Elutia Inc
NASDAQ: ELUT0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- C. Randal Mills
- Employees
- 26
- Headquarters
- Gaithersburg, United States
- IPO year
- 2020
- Market cap
- $43.4M
- Website
- https://elutia.com
Loading ELUT…
Loading profile data…Frequently asked questions about ELUT
What does Elutia Inc (ELUT) do?
Elutia Inc., a commercial-stage company, focuses on developing drug-eluting biomatrix products for use in surgical reconstruction and related applications. The company operates in two segments, Women’s Health and Cardiovascular. Its lead development programs include NXT-41 and NXT-41x, which are designed as biologic scaffolds combined with local...
Where does ELUT trade?
Elutia Inc (ELUT) trades on the NASDAQ.
What sector is ELUT in?
Elutia Inc (ELUT) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Elutia Inc?
C. Randal Mills is the chief executive officer of Elutia Inc (ELUT).
Where is Elutia Inc headquartered?
Elutia Inc is headquartered in United States.
Does ELUT pay a dividend?
Elutia Inc (ELUT) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELUT go public?
Elutia Inc (ELUT) completed its initial public offering in 2020.